Statin use and calcific uremic arteriolopathy: a matched case-control study.
about
Calciphylaxis: risk factors, diagnosis, and treatmentQuantifying a rare disease in administrative data: the example of calciphylaxisHigh Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trialThe Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE TrialCalciphylaxis in Patients With Preserved Kidney Function.Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis.Calciphylaxis in peritoneal dialysis patients: a single center cohort study.Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder.Calciphylaxis: from the disease to the diseased.A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors.Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis.Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis?Evolving calciphylaxis--what randomized, controlled trials can contribute to the capture of rare diseases.Vitamin D receptor activation: cardiovascular and renal implications.Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.Increased Bone Morphogenetic Protein Signaling in the Cutaneous Vasculature of Patients with Calciphylaxis.The protective effect of different dialysis types on residual renal function in patients with maintenance hemodialysis: A systematic review and meta-analysis
P2860
Q28084969-EB6CEFF9-E3BD-47CE-BAE6-7977880DEC4AQ30836782-9046174D-E460-48ED-839F-1FDB538D3143Q33776200-EE87F075-4807-4DA7-99A8-3119C1EC2753Q35576155-069847A0-7D72-4103-8819-50548FDD14BEQ36051236-B62921BA-EFC7-423D-B80D-1D339A7A365EQ36069462-AD012C40-E1E7-44CA-BD58-E171675F0295Q37279635-F0D84FB8-DC58-4FB9-9A25-6B099E86580DQ38182939-B4E512DB-086D-44A5-8E5A-3C58C038D90DQ38402043-B5DF0FB4-FCDB-45E0-8269-C86AA0DFFCCCQ38801820-088893C0-1A66-478E-8577-13DFB2CB09D1Q40397629-FCE6CFF8-442B-4957-922D-F0B2D15C3290Q40837665-CDD38390-3CA1-4504-AC8D-5D0BA15AAA70Q42569047-9FA00E86-955F-4A0B-93C3-D6510AA4496DQ42727505-4657FBFF-EF66-438F-8DF2-EABD503F6626Q44928316-879B77BF-5B03-4A8C-BF1E-136CB9AA55BFQ47231423-A5BDA347-B7F5-4730-AE48-5DBD8CBB5175Q58739627-D77733A6-B8B5-4649-9944-3BF7003EC123
P2860
Statin use and calcific uremic arteriolopathy: a matched case-control study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Statin use and calcific uremic arteriolopathy: a matched case-control study.
@ast
Statin use and calcific uremic arteriolopathy: a matched case-control study.
@en
type
label
Statin use and calcific uremic arteriolopathy: a matched case-control study.
@ast
Statin use and calcific uremic arteriolopathy: a matched case-control study.
@en
prefLabel
Statin use and calcific uremic arteriolopathy: a matched case-control study.
@ast
Statin use and calcific uremic arteriolopathy: a matched case-control study.
@en
P2093
P2860
P356
P1476
Statin use and calcific uremic arteriolopathy: a matched case-control study.
@en
P2093
Alexander Turchin
Ananth Karumanchi
David Steele
Ishir Bhan
Julia Wenger
Ravi Thadhani
Reza Hajhosseiny
Rosalynn M Nazarian
Sagar U Nigwekar
Samir Parikh
P2860
P304
P356
10.1159/000348806
P577
2013-03-21T00:00:00Z